U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693894) titled 'DISARM Clinical Study B: Evaluation of Innovative Ovarian Cancer Biomarker Assays' on July 05.
Brief Summary: Ovarian cancer is often diagnosed at a later stage because early symptoms can be mild or non-specific. Earlier detection of ovarian cancer could improve treatment options and outcomes.
Recent research has focused on the development of blood-based tests, sometimes referred to as liquid biopsy tests, which aim to look for changes in the blood that could be linked to cancer. These tests are still under investigation and are not part of routine clinical care.
The purpose of this study is to evaluate several blood-based ovarian...